Is (ALEC) Outperforming Other Medical Stocks This Year?
Franklin Resources Inc. grew its position in Alector Inc (NASDAQ:ALEC) by 41.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fu
Charles Schwab Investment Management Inc. grew its stake in Alector Inc (NASDAQ:ALEC) by 2.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchang
Alector Inc (NASDAQ:ALEC) has earned an average recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock wit
Barclays PLC boosted its stake in shares of Alector Inc (NASDAQ:ALEC) by 91.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The i
Investors need to pay close attention to Alector (ALEC) stock based on the movements in the options market lately.
Investors need to pay close attention to Alector (ALEC) stock based on the movements in the options market lately.
The Alector, Inc. (NASDAQ:ALEC) share price has had a bad week, falling 14%. But that doesn't change the reality that...
Rhumbline Advisers grew its position in Alector Inc (NASDAQ:ALEC) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC
New York State Common Retirement Fund raised its position in Alector Inc (NASDAQ:ALEC) by 2.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 27,200 share
Alector (NASDAQ:ALEC) and Genocea Biosciences (NASDAQ:GNCA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, val
Kohlberg Kravis Roberts increased its stake in casual dining and entertainment chain Dave & Busters.
ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with Buy rating and $69 (55% upside) price target at Citigroup.Alector (NASDAQ:ALEC) initiated with Buy rating and $40 (36% upside) price target at Citi.
Alector (NASDAQ:ALEC) was upgraded by ValuEngine from a “sell” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports. Several other equities analysts have also commente
Barclays initiated coverage on shares of Alector (NASDAQ:ALEC) in a research report released on Thursday morning, The Fly reports. The firm issued an overweight rating on the stock. ALEC has been the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE